Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.4900 (-1.7%) ($5.4900 - $5.4900) on Thu. Apr. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.61% (three month average) | RSI | 40 | Latest Price | $5.4900(-1.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.9% a day on average for past five trading days. | Weekly Trend | ANPC declines -2.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) URA(23%) IGOV(16%) BLOK(15%) GDX(15%) GDXJ(15%) | Factors Impacting ANPC price | ANPC will decline at least -4.305% in a week (0% probabilities). SHY(-26%) CEMB(-20%) UNG(-13%) XLC(-8%) VCSH(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.305% (StdDev 8.61%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.41(-289.62%) | Resistance Level | $6.02 | 5 Day Moving Average | $5.57(-1.44%) | 10 Day Moving Average | $5.75(-4.52%) | 20 Day Moving Average | $6.02(-8.8%) | To recent high | -35.1% | To recent low | 0% | Market Cap | $47m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |